Drugs Made in America Acq-RTDMIIRPreferred / convertible

13F holders, Q4 2025 (December 31)
47holders
2famous investors
$0.14avg. 13F price*

At the end of Q4 2025, 47 institutions reported holding Drugs Made in America Acq-RT (DMIIR) in their 13F filings. The largest holders were Magnetar Financial LLC ($378K), First Trust Capital Management L.P. ($290K) and Hudson Bay Capital Management LP ($276K). 2 famous investors held it, including Israel Englander ( of Millennium Management's portfolio) and David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Drugs Made in America Acq-RT
CUSIP
G2851K112
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q4 2025: 47Q4 2025Q1 2026: 57Q1 2026Q2 2026: 62Q2 2026

Total Exit/New Position Q4 2025

InstitutionsTotal Value
New Positions4$178K
Exits0$0

Ownership 47 holders

Magnetar Financial LLC — No change 2,700,000 $378K
First Trust Capital Management L.P. — Add +10.0% 2,068,118 $290K
Hudson Bay Capital Management LP — No change 1,969,030 $276K
Glazer Capital, LLC — Reduce -19.1% 1,899,899 $266K
Toronto Dominion Bank — Add +366.6% 1,633,000 $229K
Millennium Management — Reduce -25.0% 1,500,000 $210K
Polar Asset Management Partners Inc. — No change 1,500,000 $210K
TENOR CAPITAL MANAGEMENT Co., L.P. — No change 1,500,000 $210K
HGC Investment Management Inc. — Add +2.6% 1,230,980 $172K
AQR Arbitrage LLC — Reduce -23.2% 1,151,400 $161K
Aristeia Capital, L.L.C. — No change 1,100,000 $154K
D. E. Shaw & Co. — No change 1,000,000 $140K
OMERS ADMINISTRATION Corp — No change 1,000,000 $140K
Davidson Kempner Capital Management LP — No change 1,000,000 $140K
Picton Mahoney Asset Management — No change 875,000 $123K
Linden Advisors LP — New 899,899 $117K
CSS LLC — Reduce -90.1% 80,600 $113K
Context Capital Management, LLC — No change 750,000 $105K
Moore Capital Management, LP — No change 750,000 $105K
Ghisallo Capital Management LLC — No change 750,000 $105K
Radcliffe Capital Management, L.P. — No change 575,000 $75K
Shaolin Capital Management LLC — Reduce -34.4% 525,000 $74K
Wolverine Asset Management LLC — Reduce -29.4% 505,057 $71K
HBK Investments L P — No change 500,000 $70K
Whitebox Advisors LLC — No change 450,000 $63K
Wealthspring Capital LLC — Reduce -0.9% 408,950 $57K
Commonwealth of Pennsylvania Public School Empls Retrmt SYS — No change 400,000 $56K
BNP Paribas Financial Markets — New 348,600 $49K
Lineage Point Capital LP — — 330,000 $46K
Alpine Global Management, LLC — No change 300,000 $42K
Sona Asset Management (us) LLC — No change 300,000 $42K
K2 Principal Fund, L.P. — Reduce -41.4% 250,000 $35K
Mint Tower Capital Management B.V. — No change 250,000 $35K
Periscope Capital Inc. — No change 250,000 $35K
Verition Fund Management LLC — Reduce -55.6% 200,000 $28K
JPMorgan Chase & Co. — No change 129,630 $18K
DLD Asset Management, LP — Add +12.2% 112,200 $16K
PEAK6 LLC — No change 100,000 $14K
Cable Car Capital, LP — No change 100,000 $14K
Quarry LP — Add +102.3% 80,900 $11K
Meteora Capital, LLC — Reduce -70.0% 60,000 $8K
Royal Bank of Canada — Reduce -22.7% 58,000 $8K
Harraden Circle Investments, LLC — New 50,000 $7K
Deltec Asset Management LLC — Reduce -11.0% 44,500 $6K
Abc Arbitrage SA — New 40,000 $6K
Clear Street Group Inc. — Reduce -92.4% 27,259 $4K
Highbridge Capital Management LLC — Reduce -96.0% 1,003 $140

"% of holder's portfolio" is DMIIR's weight in each manager's 13F, not the share of Drugs Made in America Acq-RT the manager owns.